Healthcare
JAZZ
Jazz Pharmaceuticals plc
About Jazz Pharmaceuticals plc
Jazz Pharmaceuticals makes medications for rare diseases and cancers. Their established drugs include Xywav for narcolepsy (a sleep disorder), Epidiolex for certain types of seizures, and several cancer treatments like Zepzelca for lung cancer and Rylaze for leukemia. The company also has numerous drugs in development, tested in patients to see if they work for conditions like brain tumors, breast cancer, and blood cancers. Jazz Pharmaceuticals was founded in 2003 and is based in Dublin, Ireland.
Full research is for ConvictionStocks members
Get Full AccessAnalyst Coverage
Full research is for ConvictionStocks members
Get Full AccessRecent News
Full research is for ConvictionStocks members
Get Full AccessGet the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Related Research
More Healthcare stocks to explore